Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Characterizing missense TLS variants
FY 2022-23
Summary
Cancer cells acquire many mutations due to the high replication burden they face. Such mutations place cancer cells at a unique disadvantage when compared to healthy cells, which can be exploited by synthetic lethal therapies. A synthetic lethal (SL) relationship refers to two genes which when individually mutated or lost retains viability however, simultaneous loss of function leads to cell death. SL therapies that have proven successful in the clinic include PARP inhibitors, which trap the PARP protein at DNA damage sites. This trapping mechanism allows protein-DNA lesions to persist and prevents redundant repair mechanisms from accessing the lesion. Cancer cells characterized by genomic instability and containing non-functional DNA damage repair pathways, are particularly susceptible to such ‘trapping’ SL inhibitors. Previously, dominant missense mutations have been used to mimic chemical inhibition resulting in protein trapping. With my project, we hope to leverage dominant missense mutations in translesion synthesis (TLS) polymerases and identify potential trapping mutants which may inform future drug design as an SL therapy. TLS’s are a particularly attractive target due to their involvement in error-prone bypass of DNA lesions during replication and several studies have highlighted their role in cancer therapy resistance. Therefore, my study will use high-throughput mutagenesis to engineer missense libraries and screen for dominant TLS variants. Dominant variants will be assessed for their trapping potential and impact on TLS function. My project will map functionally important residues of TLS’s and identify their potential as SL therapeutic targets to inform future drug design.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486482
Name
Cozma Ecaterina
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing missense TLS variants
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Therapy; Dna Damage Repair; Genomic Instability; High-Throughput Mutagenesis; Rev1; Rev3; Synthetic Lethal; Translesion Synthesis
Abstract
Cancer cells acquire many mutations due to the high replication burden they face. Such mutations place cancer cells at a unique disadvantage when compared to healthy cells, which can be exploited by synthetic lethal therapies. A synthetic lethal (SL) relationship refers to two genes which when individually mutated or lost retains viability however, simultaneous loss of function leads to cell death. SL therapies that have proven successful in the clinic include PARP inhibitors, which trap the PARP protein at DNA damage sites. This trapping mechanism allows protein-DNA lesions to persist and prevents redundant repair mechanisms from accessing the lesion. Cancer cells characterized by genomic instability and containing non-functional DNA damage repair pathways, are particularly susceptible to such ‘trapping’ SL inhibitors. Previously, dominant missense mutations have been used to mimic chemical inhibition resulting in protein trapping. With my project, we hope to leverage dominant missense mutations in translesion synthesis (TLS) polymerases and identify potential trapping mutants which may inform future drug design as an SL therapy. TLS’s are a particularly attractive target due to their involvement in error-prone bypass of DNA lesions during replication and several studies have highlighted their role in cancer therapy resistance. Therefore, my study will use high-throughput mutagenesis to engineer missense libraries and screen for dominant TLS variants. Dominant variants will be assessed for their trapping potential and impact on TLS function. My project will map functionally important residues of TLS’s and identify their potential as SL therapeutic targets to inform future drug design.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cozma, Ecaterina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~